254 related articles for article (PubMed ID: 33308502)
1. Management of Acute Kidney Injury in Coronavirus Disease 2019.
Shaikh S; Matzumura Umemoto G; Vijayan A
Adv Chronic Kidney Dis; 2020 Sep; 27(5):377-382. PubMed ID: 33308502
[TBL] [Abstract][Full Text] [Related]
2. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
Khoo BZE; Lim RS; See YP; Yeo SC
BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
[TBL] [Abstract][Full Text] [Related]
3. Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.
Deep A; Bansal M; Ricci Z
Blood Purif; 2021; 50(2):150-160. PubMed ID: 32663827
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
Arnold F; Westermann L; Rieg S; Neumann-Haefelin E; Biever PM; Walz G; Kalbhenn J; Tanriver Y
BMC Nephrol; 2020 Nov; 21(1):486. PubMed ID: 33198670
[TBL] [Abstract][Full Text] [Related]
5. Sustained low-efficiency dialysis with regional citrate anticoagulation in critically ill patients with COVID-19 associated AKI: A pilot study.
Di Mario F; Regolisti G; Di Maria A; Parmigiani A; Benigno GD; Picetti E; Barbagallo M; Greco P; Maccari C; Fiaccadori E
J Crit Care; 2021 Jun; 63():22-25. PubMed ID: 33611151
[TBL] [Abstract][Full Text] [Related]
6. Provision of acute renal replacement therapy, using three separate modalities, in critically ill patients during the COVID-19 pandemic. An after action review from a UK tertiary critical care centre.
Fisher R; Clarke J; Al-Arfi K; Saha R; Lioudaki E; Mehta R; Pahl C; Sharpe C; Bramham K; Hutchings S
J Crit Care; 2021 Apr; 62():190-196. PubMed ID: 33422809
[TBL] [Abstract][Full Text] [Related]
7. Deployment of a New CRRT/PIRRT Device during the COVID-19 Pandemic Emergency: Organizational Challenges and Implementation Results.
Yessayan LT; Heung M; Girard FA; Shaikhouni S; Szamosfalvi B
Blood Purif; 2021; 50(3):390-398. PubMed ID: 33171460
[TBL] [Abstract][Full Text] [Related]
8. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
[TBL] [Abstract][Full Text] [Related]
9. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study.
Valle EO; Cabrera CPS; Albuquerque CCC; Silva GVD; Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Lins PRG; Rodrigues CE
Crit Care; 2021 Aug; 25(1):299. PubMed ID: 34412667
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation for renal replacement therapy for patients with acute kidney injury.
Nongnuch A; Tangsujaritvijit V; Davenport A
Minerva Urol Nefrol; 2016 Feb; 68(1):87-104. PubMed ID: 26473371
[TBL] [Abstract][Full Text] [Related]
11. Ensuring Sustainability of Continuous Kidney Replacement Therapy in the Face of Extraordinary Demand: Lessons From the COVID-19 Pandemic.
Chua HR; MacLaren G; Choong LH; Chionh CY; Khoo BZE; Yeo SC; Sewa DW; Ng SY; Choo JC; Teo BW; Tan HK; Siow WT; Agrawal RV; Tan CS; Vathsala A; Tagore R; Seow TY; Khatri P; Hong WZ; Kaushik M
Am J Kidney Dis; 2020 Sep; 76(3):392-400. PubMed ID: 32505811
[TBL] [Abstract][Full Text] [Related]
12. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.
Nadim MK; Forni LG; Mehta RL; Connor MJ; Liu KD; Ostermann M; Rimmelé T; Zarbock A; Bell S; Bihorac A; Cantaluppi V; Hoste E; Husain-Syed F; Germain MJ; Goldstein SL; Gupta S; Joannidis M; Kashani K; Koyner JL; Legrand M; Lumlertgul N; Mohan S; Pannu N; Peng Z; Perez-Fernandez XL; Pickkers P; Prowle J; Reis T; Srisawat N; Tolwani A; Vijayan A; Villa G; Yang L; Ronco C; Kellum JA
Nat Rev Nephrol; 2020 Dec; 16(12):747-764. PubMed ID: 33060844
[TBL] [Abstract][Full Text] [Related]
13. Faster Blood Flow Rate Does Not Improve Circuit Life in Continuous Renal Replacement Therapy: A Randomized Controlled Trial.
Fealy N; Aitken L; du Toit E; Lo S; Baldwin I
Crit Care Med; 2017 Oct; 45(10):e1018-e1025. PubMed ID: 28658026
[TBL] [Abstract][Full Text] [Related]
14. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience.
Shankaranarayanan D; Muthukumar T; Barbar T; Bhasin A; Gerardine S; Lamba P; Leuprecht L; Neupane SP; Salinas T; Shimonov D; Varma E; Liu F
Clin J Am Soc Nephrol; 2020 Dec; 16(1):124-126. PubMed ID: 32943397
[No Abstract] [Full Text] [Related]
16. Regional citrate anticoagulation for continuous renal replacement therapy in children.
Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
[TBL] [Abstract][Full Text] [Related]
17. Acute kidney injury requiring renal replacement therapy during the COVID-19 pandemic: what are our options for treating it in Latin America?
Rizo-Topete LM; Claure-Del Granado R; Ponce D; Lombardi R
Kidney Int; 2021 Mar; 99(3):524-527. PubMed ID: 33388364
[No Abstract] [Full Text] [Related]
18. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
Trials; 2014 Nov; 15():449. PubMed ID: 25409678
[TBL] [Abstract][Full Text] [Related]
19. Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States.
Reddy YNV; Walensky RP; Mendu ML; Green N; Reddy KP
Am J Kidney Dis; 2020 Nov; 76(5):696-709.e1. PubMed ID: 32730812
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012467. PubMed ID: 32164041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
